Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia and Brain Functional Connectivity in Chronic Pain and Refractory Depression
NCT02196259Terminated
- Sponsor
- University of Michigan
- Start
- Feb 2008
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ketamine in chronic pain and major depressive disorder (MDD) (3 arms), sponsored by University of Michigan. Primary endpoint: Functional Connectivity. Started Feb 2008; status: terminated.
02
Drugs
ketamine
03
Conditions
chronic painmajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02196259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02196259.